Home johnson johnsons
 

Keywords :   


Tag: johnson johnsons

Johnson & Johnson's Outlook

2016-03-29 13:57:34| Biotech - Topix.net

It's time to take a look at Johnson & Johnson's valuation again, because I like to review all of my long-term stock holdings at least once per year. Currently, I am not holding a whole lot of value in the US stock market.

Tags: johnson outlook johnsons johnson johnsons

 

Johnson & Johnson's Growing Drug Dependency Makes The Business More Unpredictable

2016-03-29 01:23:06| Biotech - Topix.net

J&J's strong Pharma performance over the past few years, coupled with tepid growth in Consumer Healthcare and Medical Devices, indicates a shift in basic revenue structure. The more they succeed at Pharma and lose growth in Consumer Healthcare, the greater their risk of unstable revenue growth.

Tags: business makes growing drug

 
 

Johnson & Johnson's Stelara Succeeds In Phase III Crohn's Disease Trial

2015-10-19 19:30:37| Food - Topix.net

Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine. Stelara, a biotech medicine that blocks inflammation, is approved to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis.

Tags: iii trial phase disease

 

Johnson & Johnson's New Drug Invega Trinza Will Help Drive Pharma Sales

2015-06-30 07:37:38| Biotech - Topix.net

Johnson & Johnson is launching the new Invega Trinza antipsychotic drug, which only needs to be taken four times a year. Together with the highly successful Invega Sustenna, Invega Trinza can help drive sales of J&J's pharma segment, which was the best performer of the company in Q1 2015.

Tags: sales drive drug johnson

 

Cardinal Health offers to buy Johnson & Johnson's Cordis business for about $1.94 billion

2015-03-02 16:33:27| Biotech - Topix.net

Cardinal Health is offering to buy a unit of Johnson & Johnson that makes heart devices for approximately $1.94 billion. Johnson & Johnson's Cordis business, which is based in Fremont, California, had 2014 revenue of about $780 million.

Tags: business buy health offers

 

Sites : [1] [2] [3] next »